A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 74.50
+0.50 (0.68%)
Aug 26, 2026, 1:30 PM CST
A Plus Biotechnology Revenue
A Plus Biotechnology had revenue of 242.94M TWD in the quarter ending June 30, 2026, with 13.58% growth. This brings the company's revenue in the last twelve months to 887.93M, up 8.94% year-over-year. In the year 2025, A Plus Biotechnology had annual revenue of 835.89M with 8.61% growth.
Revenue (ttm)
887.93M
Revenue Growth
+8.94%
P/S Ratio
2.84
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.52B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 835.89M | 66.30M | 8.61% |
| Dec 31, 2024 | 769.59M | 94.54M | 14.01% |
| Dec 31, 2023 | 675.05M | 59.57M | 9.68% |
| Dec 31, 2022 | 615.48M | 73.63M | 13.59% |
| Dec 31, 2021 | 541.85M | 38.56M | 7.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wellell | 2.50B |
| OK Biotech | 1.54B |
| Dynamic Medical Technologies | 1.40B |
| WeLeader Biomedical | 1.21B |
| AViTA | 972.61M |
| Bioptik Technology Incorporation | 912.86M |
| Medimaging Integrated Solution | 682.01M |
| Applied BioCode | 666.54M |